New combo therapy may ease shoulder pain in breast cancer survivors
NCT ID NCT02735668
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a combination of physiotherapy techniques—including dry needling, nerve gliding exercises, and scapula strengthening—works better than exercise alone for women with ongoing shoulder pain after breast cancer treatment. Ninety women were randomly assigned to one of three groups: multimodal physiotherapy, scapula exercises, or conventional shoulder exercises. The goal was to see which approach best reduced pain and disability and improved quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- multimodal physiotherapy (dry needling, neurodynamic techniques, and scapula exercises)
- What this could lead to
- If successful, this could offer a more effective, non-drug approach to ease persistent shoulder pain and improve quality of life in breast cancer survivors.
- What could go wrong
- This is a small, completed trial with 90 participants, so results may not apply to all women. The intervention is complex and requires skilled therapists, limiting widespread use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
Apr 2016
- Finished
-
Apr 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women with peripheral persistent pain following breast cancer treatment (surgery and/or radiotherapy and/or chemotherapy) with pain for at least 6 months. * Women who do not present contraindications for physiotherapy (infection, metastasis, locoregional recurrence). * Women who have read, understood and signed informed consent freely Exclusion Criteria: * Women treated with bilateral breast cancer. * Women with shoulder pain episodes prior to breast cancer treatment. * Women with predominant central sensitization pain identified by the Central Sensitization Inventory (\> 40 points) * Women with cognitive limitations to understand the information provided, instructions for treatment and consent to their participation in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Teacher care and research in physiotherapy Unit. Department of Physiotherapy. University of Alcala.
Alcalá de Henares, Madrid, 28871, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?